Bharat Biotech is seeking to raise over $500 million through an IPO. Discussions are ongoing, and details may change. Established in 1996, the company has distributed over 9 billion vaccines worldwide, including those for Covid-19 and hepatitis B.

Bharat Biotech IPO soon? Vaccine maker plans to raise $500 million from stock market, says report

Vaccine Developer Bharat Biotech Eyes $500 Million IPO

Bharat Biotech International Ltd, a leading vaccine developer, is reportedly exploring the possibility of raising over $500 million through an initial public offering (IPO), according to a recent Bloomberg report.

The potential deal, which is still in its early stages, is expected to be finalized in the near future, although the specifics of the deal, including its size and timing, may be subject to change.
Those familiar with the matter have chosen to remain anonymous, citing the private nature of the discussions.

About Bharat Biotech

Bharat Biotech International Ltd was founded in 1996 and has since become a prominent player in the global vaccine market. The company claims to have distributed over 9 billion vaccines worldwide, making it a significant contributor to global healthcare.